Gesine Paul-Visse
11 – 20 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pericyte-Specific Secretome Profiling in Hypoxia Using TurboID in a Multicellular in Vitro Spheroid Model
- Contribution to journal › Article
- 2023
-
Mark
DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes–Induced Blood–Brain Barrier Leakage and Normalize Capillary Pericyte Coverage
- Contribution to journal › Article
-
Mark
Molecular Regulation of the Response of Brain Pericytes to Hypoxia
- Contribution to journal › Scientific review
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
- Contribution to journal › Article
-
Mark
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease : A Randomized, Double-Blind, Multicenter Phase 1 Trial
- Contribution to journal › Article
-
Mark
Nu testas banbrytande en behandling för patienter med Parkinsons sjukdom
- Contribution to specialist publication or newspaper › Specialist publication article
- 2022
-
Mark
RGS5 : a novel role as a hypoxia-responsive protein that suppresses chemokinetic and chemotactic migration in brain pericytes
- Contribution to journal › Article
-
Mark
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
- Contribution to journal › Scientific review
-
Mark
Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice
- Contribution to journal › Article
- 2021
-
Mark
Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
- Contribution to journal › Article
